Abstract We previously identified and characterized four galectin-1-like proteins in zebrafish, Drgal1-L1, Drgal1-L2, Drgal1-L3, and one splice variant of Drgal1-L2, of distinct ontogenic expression. Drgal1-L1 is maternal; Drgal1-L2 is zygotic and strongly expressed in the notochord, while Drgal1-L3 is both maternal and zygotic. Knockdown experiments in zebrafish embryos using a morpholinomodified antisense oligo targeted to the 5'-UTR sequence of Drgal1-L2 resulted in a phenotype with a bent tail and disorganized muscle fibers. This effect was dose-dependent as follows: 62-66% at 17 ng, 29-35% at 5.7 ng, 21-28% at 1.9 ng, and 14-17% at 0.6 ng. However, no (or a negligible number of) Drgal1-L1 knockdown embryos showed similar morphological defects, indicating that the observed effects are sequence-specific, and not due to the toxicity of the morpholino-modified oligos. Further, ectopic expression of native Drgal1-L2 specifically rescued the phenotype, as coinjection of the full-length sense Drgal1-L2 mRNA with Drgal1-L2-MO yielded 60-62% normal embryos. As the notochord serves as the primary source of signaling molecules required for proper patterning of adjacent tissues, such as neural tube, somites, and heart, these results suggest that galectins produced by the notochord play a key role in somitic cell differentiation and development.
making it possible to visualize the effects of genes involved in developmental processes, such as organogenesis, etc. Second, the early expression of these gene(s) can easily be manipulated in zebrafish embryos by various approaches such as dominant negative and antisense knockdowns, enabling visualization of effects of their normal or experimentally-modified expression. Third, a growing collection of mutations that affects early embryonic development has been characterized and mapped, providing a powerful resource for genetic studies on the function and mechanisms of action of developmentally-regulated genes. More importantly, many orthologous genes are shared among zebrafish, mouse, and man. This feature represents a significant advantage of zebrafish over other developmental models such as C. elegans and Drosophila, which lack genes mediating adaptive immunity, some aspects of neurological processing, and other functions typical of vertebrates.
We previously identified four galectin-1-like proteins in zebrafish, Drgal1-L1, Drgal1-L2, Drgal1-L3, and one splice variant of Drgal1-L2, and examined their ontogenic expression. Drgal1-L1 is maternal; Drgal1-L2 is zygotic, while Drgal1-L3 is both maternal and zygotic [18] . In this study, we identified a phenotype with a short/bent tail and disorganized muscle fibers resulting from disrupting its expression by a morpholino-modified antisense oligo targeted to the 5'-UTR sequence of Drgal1-L2. As the notochord serves as the primary source of signaling molecules required for proper patterning of adjacent tissues, such as neural tube, somites, and heart, galectins produced by the notochord may also play a key role in somitic cell differentiation and development.
Materials and methods
Reagents The monoclonal antibody F59 (specific for isoforms of myosin heavy chain associated with slow contracting muscle) was obtained from the Developmental Studies Hybridoma Bank, The University of Iowa (Iowa City, IA). Morpholino antisense oligos for translation blockers were based on the sequence near the ATG start site and were custom-synthesized by Gene Tools (Carvalis, OR). The morpholino antisense oligos were as follows: Drgal1-L1-MO: 5'-TGTATAAGCACAGTCTCATGCA-3'; Drgal1-L2-MO: 5'-ATAAGCACACCGGCCATTTT-GACGT-3'; standard control morpholino: 5'-CCTCTT-ACCTCAGTT-ACAATTTATA-3'. All other reagents were of the highest grade commercially available.
Maintenance of zebrafish and collection of embryos Zebrafish (Danio rerio, Cyprinidae) were raised according to the standard method previously described [19] . At the onset of light, one female and one male fish were placed in an embryo collection tank at 28.5°C and fertilized embryos were collected within an hour after mating and used for microinjection.
Whole mount in situ hybridization and immunostaining In situ hybridization and immunostaining were carried out following the protocols previously described [18] .
Validation of the morpholino-modified antisense oligonucleotide (Drgal1-L2-MO) by in vitro blocking of Drgal1-L2 protein expression In vitro direct translation of Drgal1-L2 was performed from pCS-Drgal1-L2 plasmid DNA (0.5 μg) using TNT SP6 Coupled Rabbit Reticulocyte Lysate System (Promega, Madison, WI) according to the manufacturer's instructions. For this purpose, Drgal1-L2 with 5'-UTR sequences was cloned into a pCS2 + vector (a gift from D. Turner, R. Rupp, J. Lee, and H. Weintraub, Fred Hutchinson Cancer Research Center, Seattle, WA) to obtain the pCS-Drgal1-L2 construct. In this construct, a 27-nucleotide untranslated 5' leader (derived from the Xenopus β-globin mRNA 5'-end) is introduced between the SP6 promoter and the Drgal1-L2 insert. The pCS-Drgal1-L2 construct is expected to generate protein, when added to a cell-free protein synthesis system that is initiated by SP6 RNA polymerase. In the presence of the Drgal1-L2-MO, however, synthesis of protein should be blocked. To detect the translated product, [
35 S]methionine was used with the methionine free amino acid mixture. For the blocking Drgal1-L2 expression, the same amount of plasmid DNA was mixed with Drgal1-L2-MO (170 ng and 340 ng). After completion of the reaction, the translated product was analyzed on 15% SDS-PAGE followed by autoradiography.
Microinjection of morpholino-modified antisense oligonucleotides into zebrafish embryos Morpholino antisense oligos were dissolved in Danieau buffer [20] to a final concentration of 0.5 mM or 1 mM and 1-2 nl was injected into the yolk of zebrafish embryos (1 to 4-cell stage) as described [21] . Five hundred embryos were injected for each antisense oligonucleotide, and raised to various stages for phenotypic analysis.
Plasmid construction and ectopic expression of native Drgal1-L2 on antisense oligo injected embryos To determine if the ectopic expression of native Drgal1-L2 rescues the phenotypes observed, Drgal1-L2 mRNAs were synthesized from a pCS-Drgal1-L2 construct using an in vitro transcription kit (mMESSAGE mMACHINE SP6, Ambion, Austin, Texas). In this construct, 27 nucleotides derived from the Xenopus β-globin 5'-UTR were used to replace the Drgal1-L2 5'-UTR as the Drgal1-L2-MO was specifically targeted to the Drgal1-L2 5'UTR. Thus, the Drgal1-L2-MO would only inhibit expression of the endogenous Drgal1-L2, but not of the injected Drgal1-L2 mRNA. The integrity of the transcribed RNA was examined on formaldehyde 1.5% agarose gels. For microinjection, mRNA was dissolved in distilled water to a final concentration of 100 μg/ml. The transcribed RNA solution (approximately 2 nl) was microinjected into the cytoplasm of zebrafish embryos at the oneor two-cell stage, and subsequently, the morpholino-modified galectin antisense oligonucleotides (17 ng) were microinjected into the yolk sac [21] .
Results and discussion

Molecular characterization of the Drgal1-L2
Sequence analysis of Drgal1-L2
The full-length cloning and sequencing of the Drgal1-L2 was previously reported [18] . Like mammalian galectin-1, the Drgal1-L2 contains all nine amino acid residues (H 44 , the numbering is based on the bovine galectin-1 sequence, [22] ) that are responsible for the carbohydrate-binding [22] [ Fig. 1] . A blast search (TBLASTN) of Drgal1-L2 protein resulted highest hit with the galectin-1 or galectin-1 like proteins from higher and lower vertebrates. Besides other galectin-1-like proteins in zebrafish such as Drgal1-L1 (78%), the highest identity was observed with galectin-1-like proteins from the Atlantic halibut (Hippoglossus hippoglossus) and the Japanese flounder Paralichthys olivaceus (63%), followed by the orange-spotted grouper (Epinephelus coioides) (62%), the spotted green pufferfish (Tetraodon nigroviridis) (57%), and the mammalian bona fide galectins, such as those from bovine, murine and human (37-40%).
Gene organization of Drgal1-L2
A blast search (TBLASTN) against the nearly completed zebrafish genome, revealed that the gene encoding Drgal1-L2 is approximately 7 kb-long, and is located in chromosome 3, ranging from 1548913 bp to 1555901 bp. Like other galectin-1 genes, the Drgal1-L2 gene contains four exons, of which exon 3 houses all the amino acid residues that bind the carbohydrate ligand. Coding sequence lengths of the four exons are as follows: exon 1, 6 bp; exon 2, 80 bp; exon 3, 171 bp; and exon 4, 147 bp) [ Fig. 2] . Overall, the genomic organization of the Drgal1-L2 gene showed similarity to the mammalian galectin-1 genes [23, 24] , including the exon-intron boundaries. 
Drgal1-L2 expression in developing zebrafish
Drgal1-L2 was intensely expressed in the notochord of the developing embryos tested up to 24 hpf (hour post fertilization) embryos [18] . In this study, older embryos up to 3 dpf (days post fertilization) were examined for Drgal1-L2 expression. In these embryos, Drgal1-L2 expression remained intense in the notochord (not shown).
Functional characterization of Drgal1-L2
Validation of the morpholino-modified antisense oligonucleotide (Drgal1-L2-MO) by in vitro blocking of Drgal1-L2 protein expression
To test if Drgal1-L2-MO can block Drgal1-L2 expression, in vitro direct translation of Drgal1-L2 was performed from the pCS-Drgal1-L2 plasmid DNA (0.5 μg) using the TNT SP6 Coupled Rabbit Reticulocyte Lysate System in the presence or absence of Drgal1-L2-MO. Drgal1-L2-MO blocked the in vitro expression of Drgal1-L2 as little or no product was seen, when the translation reaction was performed in the presence of Drgal1-L2-MO [ Fig. 3A, lanes 2 and 3] . Results from pCSDrgal1-L2 plasmid DNA without Drgal1-L2-MO showed a single band corresponding to expected size of Drgal1-L2 (approximately 14 kDa) [Fig. 3A, lane 1] .
Validation of the Drgal1-L2-MO by in vivo blocking of Drgal1-L2 protein expression
To determine if the injection of antisense oligos effectively blocked Drgal1-L2 protein expression in vivo, whole mount antibody staining was performed on injected embryos. Compared with the control (uninjected) embryos [ Fig. 3B ], injected embryos showed dramatically reduced or no Drgal1-L2 expression [ Fig. 3C ].
Identification of a phenotype in the Drgal1-L2-MO-knockdown
Knockdown experiments using Drgal1-L2-MO resulted in embryos with a bent tail [ Fig. 3D , see also Fig. 3C inset] and disrupted organization of the muscle fibers [ Fig. 3F ].
The phenotype was dose-dependent as follows: 62-66% at 17 ng, 29-35% at 5.7 ng, 21-28% at 1.9 ng, and 14-17% at 0.6 ng (Table 1) . However, a negligible number of embryos showed morphological defects when injected with the Drgal1-L1-MO (not shown), indicating that the observed effect is sequence-specific and not due to the toxicity of the morpholino-modified oligos themselves. The disorganized muscle was prominent as judged by whole mount immunostaining with the slow muscle marker F59 antibody (monoclonal anti-myosin antibody) (Fig. 4A,B) and in situ hybridization with myod (specific for both fast and slow muscle) (Fig. 4C,D) . The specificity of the phenotype was validated by rescue experiments. To determine if ectopic expression of Drgal1-L2 could rescue the phenotype, full-length sense Drgal1-L2 mRNA was co-injected with Drgal1-L2-MO. Because the 5'-UTR sequence of Drgal1-L2 mRNA was replaced by a β-globin gene 5'-UTR, it cannot be recognized by Drgal1-L2-MO. This ectopic expression of native Drgal1-L2 specifically rescued the phenotype, as co-injection yielded 60-62% of normal embryos.
The results from this study suggest that the Drgal1-L2 produced/secreted by the notochord plays a key role in somitic cell differentiation and development, since blocking of Drgal1-L2 expression appears to affect skeletal muscle formation resulting in disrupted myofibril organization. Previous reports strongly suggest the role of galectin-1 in muscle differentiation by direct interactions with the myoblast or its precursors in the local environment [25, 26] . Recent in vitro and in vivo studies on myoblasts from a galectin-1 null mouse have rigorously demonstrated the direct role of galectin-1 in skeletal muscle development and regeneration [27] . Myoblasts derived from the galectin-1 null mouse exhibit decreased fusion in vitro, whereas a delay in muscle fiber development takes place in the null mouse neonatal stage, and a reduced muscle fiber diameter is observed in the adult. Similarly, a regeneration delay and reduced fiber size is observed during muscle recovery from experimental injury [27] . Further, galectin-1 has been implicated in the differentiation of stem cells into muscle fibers. When human fetal mesenchymal stem cells are exposed in vitro to galectin-1, about two thirds will differentiate into a muscle phenotype, consisting of multinucleated fibers that express both desmin and myosin. If the galectin-1-exposed cells are transplanted into regenerating murine muscle they form 4-fold more human muscle fibers than the unexposed cells. These and similar results obtained in a scid/mdx dystrophic mouse model, underscore the considerable myogenic potential of the galectin-1-exposed stem cells for intervention in degenerative muscle diseases, such as muscular dystrophies [28] .
Based on the studies described herein, however, an alternative and potentially earlier mechanism for galectin-1 function in muscle development can be proposed. During early embryogenesis, the notochord serves as the primary source of signal molecules required for proper patterning of adjacent tissues, such as neural tube, somites, heart [29] [30] [31] . The bone morphogenic protein expressed in lateral mesoderm, plays a major role in promoting blood and heart development, activities that are modulated by its antagonist, Noggin, expressed in notochord [29] . The Wnt signaling molecules, including Wnt11, expressed in the notochord [30] , and Wnt3a and Wnt8, produced by the neural tube, also influence strongly the formation of heart tissue and blood [31] . Furthermore, hedgehog signals secreted from the notochord play an important role in slow muscle induction [32] [33] [34] . The unique spatial expression and tissue localization of Drgal1-L2 in the notochord (but not in the myotome) of the early embryos at the time the knockdown experiments are carried out, and the distant tissue affected by disruption of Drgal1-L2 gene expression strongly suggest that at this developmental stage its role(s) in somitic cell differentiation and development may be indirect, that is by initiating or modulating signaling pathways originated in the notochord, rather than direct interactions between cells or cells and the ECM in the local environment of the somites that would take place at later developmental stages.
